Navigation Links
Imperial Tobacco - 2010 Half Year Results Interviews

LONDON, April 27, 2010 /PRNewswire-FirstCall/ -- Imperial Tobacco today announces strong half year results against a challenging market backdrop. In a video interview with online financial broadcaster, Chief Executive Gareth Davis states, "it's been a very good first half which demonstrates the resilience of our business and the success of our enhanced focus on sales".

Davis hands over the reins of the leading international tobacco company to Chief Operating Officer Alison Cooper next month and says the Board couldn't have chosen a more able successor.

"Alison's leadership qualities, her experience and her drive and energy will ensure that the business is driven forward, taking advantage of our portfolio, our operating platform and the skills of the people that we have."

The interview and transcript are available now on, the online financial broadcaster, features in-depth interviews, documentaries and webcasts with senior company executives. If you would like to contact us, please email or phone +44-207-936-1352.

SOURCE Imperial Tobacco Group PLC
Copyright©2010 PR Newswire.
All rights reserved

Related biology news :

1. KAUST announces academic excellence alliance partnership with Imperial College London
2. Imperial College London and NTU collaborate to offer joint Ph.D. programs in engineering and science
3. Does the desire to consume alcohol and tobacco come from our genetic makeup?
4. Scientists discover how cigarette smoke causes cancer: Study points to new treatments, safer tobacco
5. Your babys brain on drugs (and alcohol and tobacco)
6. UT researchers find link between advertising and increased tobacco use among Indias youth
7. Infection blocks lungs protective response against tobacco smoke
8. Novel bioreactor enhances interleukin-12 production in genetically modified tobacco plants
9. Tobacco makes medicine
10. Women more vulnerable to tobacco carcinogens, new results show
11. Novel mechanism revealed for increasing recombinant protein yield in tobacco
Post Your Comments:
(Date:5/3/2016)...  Neurotechnology, a provider of high-precision biometric identification ... Identification System (ABIS) , a complete system for ... can process multiple complex biometric transactions with high ... face or iris biometrics. It leverages the core ... MegaMatcher Accelerator , which have been used in ...
(Date:4/19/2016)... April 20, 2016 The new ... a compact web-based "all-in-one" system solution for all door ... reader or the door interface with integration authorization management ... control systems. The minimal dimensions of the access control ... the building installations offer considerable freedom of design with ...
(Date:3/31/2016)...   LegacyXChange, Inc. ... LegacyXChange is excited to release its first ... be launched online site for trading 100% guaranteed authentic ... also provide potential shareholders a sense of the value ... industry that is notorious for fraud. The video is ...
Breaking Biology News(10 mins):
(Date:6/27/2016)... /PRNewswire/ - BIOREM Inc. (TSX-V: BRM) ("Biorem" or "the Company") ... shareholders, Clean Technology Fund I, LP and Clean Technology ... based venture capital funds which together hold approximately 59% ... diluted, as converted basis), that they have entered into ... holdings in Biorem to TUS Holdings Co. Ltd. ("TUS") ...
(Date:6/27/2016)... ... June 27, 2016 , ... Rolf K. Hoffmann, former ... of the University of North Carolina Kenan-Flagler Business School effective June ... UNC Kenan-Flagler, with a focus on the school’s international efforts, leading classes and ...
(Date:6/24/2016)... ... June 24, 2016 , ... While the majority of commercial spectrophotometers ... 5000 and the 6000i models are higher end machines that use the more unconventional ... spectrophotometer’s light beam from the bottom of the cuvette holder. , FireflySci has ...
(Date:6/23/2016)... 2016 /PRNewswire/ - FACIT has announced the creation ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" or "the ... a portfolio of first-in-class WDR5 inhibitors for the ... WDR5 represent an exciting class of therapies, possessing ... for cancer patients. Substantial advances have been achieved ...
Breaking Biology Technology: